background research reveal angiotensinconvert enzyme inhibitor ace angiotensin ii receptor blocker arb may prevent cancer hepatocellular carcinoma cc compare chemoprevent effect highrisk popup heat b virus hb c hc infect yet investing method cohort hypertens patient without history recruit three link nation database taiwan classify two group base ace arb exposure within init six month init antivirus agent intergroup differ clinic characters draw drug studi period value picfree survive compare use logan test cultivar cox regrets include timedepend variable use medic apply adjust compound result among respect median draw nonexposur v signifies differ observe risk year adjust morbid name liver cirrhosi dialect mellitus dm hyperlipidemia aspirin metformin station hazard ratio hr config inter ci cohort increase assoc hr concur protect factor ade effect standard dosage complete safe electron supplementary mater online version article sy contain avail author user 